Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncternal Therapeutics Inc
(NQ:
ONCT
)
6.538
-0.272 (-3.99%)
Streaming Delayed Price
Updated: 3:43 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oncternal Therapeutics Inc
< Previous
1
2
3
4
Next >
40 Stocks Moving In Tuesday's Mid-Day Session
May 31, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped 360.8% to $9.86 after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 31, 2022
Welcome back and get ready because we're starting off the week with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Oncternal Discontinues Enrollment In ONCT-216 Study For Soft Tissue Cancer
April 13, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 08, 2022
During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap...
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
Analyzing Oncternal Therapeutics's Unusual Options Activity
August 06, 2021
On Friday, shares of Oncternal Therapeutics (NASDAQ:ONCT) ...
Via
Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
May 31, 2022
Gainers Performance Shipping Inc. (NASDAQ: PSHG) rose 41.7% to $ 0.94 in pre-market trading. Performance Shipping shares dipped around 64% on Friday after the company announced the pricing of an...
Via
Benzinga
70 Biggest Movers From Friday
May 31, 2022
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...
Via
Benzinga
Mid-Afternoon Market Update: Dow Gains 500 Points; Red Robin Gourmet Burgers Shares Spike Higher
May 27, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 500 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 27, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 27, 2022
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
May 27, 2022
Gainers Adicet Bio, Inc. (NASDAQ: ACET) rose 16% to $11.90 in pre-market trading after reporting positive clinical update from ADI-001 Phase 1 Trial in relapsed/refractory Non-Hodgkin’s Lymphoma.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 26, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022
May 10, 2022
Upgrades
Via
Benzinga
Oncternal Therapeutics's Earnings Outlook
May 04, 2022
Oncternal Therapeutics (NASDAQ:ONCT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
99 Biggest Movers From Yesterday
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 02, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...
Via
Benzinga
Vaccinex And 4 Other Penny Stocks Bought By Insiders
February 01, 2022
The unemployment rate in the Eurozone dropped to a record low of 7% in December from a revised 7.1% level in the previous month, helping the STOXX Europe 600 Index record gains this morning. Investors,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 04, 2022
On Monday, 78 companies set new 52-week lows. Key Facts About Today's 52-Week Lows: Citigroup (NYSE:C) was the biggest company by market cap to set a new 52-week low....
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 31, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
January 06, 2022
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited...
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
January 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...
Via
Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
January 05, 2022
Gainers Wejo Group Ltd (NASDAQ: WEJO) rose 37% to $8.63 in pre-market trading after the company announced a new connected vehicle platform with Microsoft, called Wejo Neural Edge...
Via
Benzinga
Oncternal, FDA In Pact For Pivotal Study Design For Zilovertam In Mantle Cell Lymphoma
January 05, 2022
The FDA and Oncternal Therapeutics Inc (NASDAQ: ONCT) have agreed on key elements of the Company's Phase 3 trial of zilovertamab for relapsed or refractory...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 04, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Oncternal Therapeutics, Inc. (ONCT) Q3 2021 Earnings Call Transcript
November 05, 2021
ONCT earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Return on Capital Employed Overview: Oncternal Therapeutics
September 02, 2021
Benzinga Pro data, Oncternal Therapeutics (NASDAQ:ONCT) reported Q2 sales of $883.00 thousand. Earnings fell to a loss of $7.69 million, resulting in a 29.05% decrease from last...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.